HB1809: Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

Engrossed House

Introduced

In Committee

Passed First Chamber

In Second Chamber

Passed Both Chambers

Enrolled/Vetoed

Summary

Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

2025-12-18 Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs House Journal 1 P. 37
2026-01-08 Public Hearing: 01/14/2026 03:00 pm GP 158
2026-01-21 Executive Session: 01/28/2026 02:30 pm GP 158
2026-02-03 Committee Report: Ought to Pass 01/28/2026 (Vote 18-0; Consent Calendar) House Calendar 6 P. 7
2026-02-12 Ought to Pass: Motion Adopted Voice Vote 02/12/2026 House Journal 4
2026-02-12 Referred to Finance 02/12/2026 House Journal 4
2026-03-09 Division III Work Session: 03/13/2026 09:00 am GP 234
2026-03-13 Executive Session: 03/17/2026 10:00 am GP 230
2026-03-19 Majority Committee Report: Inexpedient to Legislate 03/17/2026 (Vote 13-11; Regular Calendar)
2026-03-19 Minority Committee Report: Ought to Pass with Amendment # 2026-1201h (NT)
2026-03-26 Inexpedient to Legislate: Motion Failed DV 127-222 03/26/2026 House Journal 9
2026-03-26 Amendment # 2026-1201h (NT): Amendment Adopted DV 248-101 03/26/2026 House Journal 9
2026-03-26 Ought to Pass with Amendment 2026-1201h: Motion Adopted Voice Vote 03/26/2026 House Journal 9
2026-03-30 Introduced 03/26/2026 and Referred to Health and Human Services; Senate Journal 7
2026-04-01 Hearing: 04/08/2026, Room 100, State House, 09:45 am; Senate Calendar 13

2025-12-18 Health, Human Services & Elderly Affairs House

2026-02-12 Finance House

2026-03-30 Health and Human Services Senate

Past Events (5)

2026-01-14 Hearing - GP 158

2026-01-28 Hearing - GP 158

2026-03-13 Hearing - GP 234

2026-03-17 Hearing - GP 230

2026-04-08 Hearing - Room 100, State House

0000-00-00 Introduced View on LegiScan State Link